Discover and read the best of Twitter Threads about #XtheXWaiver
Most recents (4)
š§µš§µš§µ
NEW STUDY:
The rate of all-cause mortality for people on Opioid Agonist Treatment (buprenorphine or methadone) was 53% LOWER than the rate when people were not on these medications. (1/x)
jamanetwork.com/journals/jamapā¦
NEW STUDY:
The rate of all-cause mortality for people on Opioid Agonist Treatment (buprenorphine or methadone) was 53% LOWER than the rate when people were not on these medications. (1/x)
jamanetwork.com/journals/jamapā¦
āThis association was consistent regardless of patient sex, age, geographic location, HIV status, and hepatitis C virus status and whether drugs were taken through injection."
AND
āAssociations were not different for methadone vs buprenorphineā (2/x)
AND
āAssociations were not different for methadone vs buprenorphineā (2/x)
The researchers found there was:
ā”ļø52% lower risk of suicide,
ā”ļø28% lower risk of cancer,
ā”ļø59% lower drug-related,
ā”ļø41% lower alcohol-related , and
ā”ļø 31% lower cardiovascular-related mortality during treatment with buprenorphine or methadone. (3/x)
ā”ļø52% lower risk of suicide,
ā”ļø28% lower risk of cancer,
ā”ļø59% lower drug-related,
ā”ļø41% lower alcohol-related , and
ā”ļø 31% lower cardiovascular-related mortality during treatment with buprenorphine or methadone. (3/x)
UPDATE š§µON FENTANYL BAN FIGHT: Iāve been quiet about #fentanyl for a min, but thatās because my days (and nights) have been very full since the start of 2021 working with a broad coalition of stakeholders to ensure that Trumpās hardline policy of class-wide scheduling of.../1
...fentanyl-related substances EXPIRES as scheduled on May 6th. ONE MONTH. Thatās all that remains before Trumpās policy of class-wide scheduling of fentanyl-related substances is set to expire. This policy was first imposed by Trump in 2018 and was renewed by Congress .../2
... for 15 months. Congress must not renew this policy. It was implemented by Trumpās DOJ as part of an aggressive enforcement-first and anti-science agenda first by Trumpās AG Sessions and then AG Barr, an unprecedented policy that automatically placed on Schedule I of the .../3
In the midst of Covid-19 coverage, I beg your indulgence for a thread both elegiac and celebratory. It presages, as they say on Twitter, "some personal news". (1/15)
I came to Pew exactly 11 years ago. Iāve been privileged to build, and work with, an amazing team. I cannot possibly name the dozens (hundreds?) of current and former staff, but a few shout outs:
Going back to the start, @gabecosel on conflict-of-interest policy and the Sunshine Act, which became law in 2010, and later on drug manufacturing quality (law in 2012), supply chain security (2013) and pharmacy compounding (2013).
Excited to share study ā¦@LarochelleMarcā© ā¦@darshaksanghaviā©, others & I did comparing effectiveness of different #opioid use disorder treatments. Bottom line- only methadone or buprenoprhine associated w/ reduced #overdose at 3 and 12 months jamanetwork.com/journals/jamanā¦
We looked at claims data for nearly 41,000 individuals w/ OUD and compared outpatient counseling, IOP, detox/residential, naltrexone, or methadone/buprenorphine to no treatment on outcomes of overdose or opioid-related ED or hospitalization at 3 months.
1st takeaway: despite evidence supporting MOUD w/ opioid agonist therapy, in this insured population only 12.5% of cohort received methadone/buprenorphine and average treatment duration was shorter than would be recommended at ~150 days.
